CD8A and neoplasm: Similar results were achieved by Gopalakrishnan et al. who showed that mice that received FMT from the R group of melanoma patients, exhibited more Faecalibacterium and greater infiltration of CD8+ cells into the tumor and fewer suppressive myeloid cells compared to mice that received FMT from NR donors.